Results 271 to 280 of about 489,677 (387)

Re: Ruben Raychaudhuri, Daniel W. Lin, R. Bruce Montgomery. Prostate cancer: a review. JAMA 2025;333:1433-46. [PDF]

Eur Urol Open Sci
Roldan-Testillano R, Sanchez-Salas R.
europepmc   +1 more source

A METHOD FOR ESTIMATION OF URINARY TOTAL 17-HYDROXYCORTICOSTEROIDS (17-KETOGENIC STEROIDS) AND ITS CLINICAL APPLICATION IN THE UROLOGY

, 1961
Satoru Fukuda
openalex   +2 more sources

Editorial Comment: Bladder Irrigation with Tap Water to Reduce Antibiotic use for Urinary Tract Infections in Catheter Users. [PDF]

Int Braz J Urol
Naspolini GZ, Averbeck MA.
europepmc   +1 more source

The diagnosis of venogenic impotence [PDF]

, 1988
Bosch, Ruud J. L. H., Bénard, Francois, Diederichs, W., Lue, Tom F., Stief, Christian Georg, Tanagho, Emil A.   +5 more
core   +1 more source

Heart Failure Induced by Darolutamide in an Older Patient With M0 Castration‐Resistant Prostate Cancer: A Case Report

IJU Case Reports, EarlyView.
ABSTRACT Introduction Androgen receptor signaling inhibitors (ARSIs) improve survival in prostate cancer; however, it may increase cardiovascular risks, especially in elderly patients with heart disease. Case Presentation A 94‐year‐old man with aortic valve stenosis, hypertension, and diabetes had a nodal metastatic progression of prostate cancer at 88 
Yoshiyuki Miyaji, Shinjiro Shimizu, Michihiro Sato   +2 more
wiley   +1 more source

Bilateral synchronous percutaneous nephrolithotomy in single session: A case from a district hospital. [PDF]

Urol Case Rep
Firmansyah MR, Novianda AH, Atmoko W, Aslim O.   +3 more
europepmc   +1 more source

INDICATIONS OF AN ANTIPLASMIN AGENT TRANS-AMCHA IN UROLOGY

, 1965
Hisao Takayasu, Tsuneo Nishiura, Etsuji Takasaki, Yasuyuki Yonese, Tsutomu Goro, Takashi Yamamoto, Takuzo Adachi, Eiichiro Shimano   +7 more
openalex   +2 more sources

Successful Management of Tumor Lysis Syndrome Following Enfortumab Vedotin Plus Pembrolizumab Therapy in Metastatic Urothelial Carcinoma: A Case Report

IJU Case Reports, EarlyView.
ABSTRACT Introduction Enfortumab vedotin plus pembrolizumab (EV + P) shows high efficacy in metastatic urothelial carcinoma (mUC), potentially increasing tumor lysis syndrome (TLS) risk. Case Presentation A 64‐year‐old man with mUC underwent surgery and adjuvant nivolumab after neoadjuvant chemotherapy.
Daigo Takemori, Ryu Shigehisa, Sho Shimasaki, Erika Yamashita, Yoshitaka Kurano, Kaya Atagi, Yuhi Ota, Shinkuro Yamamoto, Hiroto Osakabe, Tomoya Nao, Tsutomu Shimamoto, Hideo Fukuhara, Nobutaka Shimizu, Satoshi Fukata, Shingo Ashida, Keiji Inoue   +15 more
wiley   +1 more source

Impact of Sodium-Glucose Cotransporter-2 Inhibitors on Post-Transurethral Resection of Bladder Tumor Infection and Prognosis. [PDF]

Diagnostics (Basel)
Nishimura N, Miyake M, Miyamoto T, Ichii D, Naoi M, Narita K, Kohashi M, Tomioka A, Torimoto K, Kawashima R, Miyazaki K, Iwao T, Inoue K, Matsubara T, Fujimoto K.   +14 more
europepmc   +1 more source